s-adenosylmethionine has been researched along with Fatty Liver, Nonalcoholic in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 25 (71.43) | 24.3611 |
2020's | 10 (28.57) | 2.80 |
Authors | Studies |
---|---|
Attia, SL; Helsley, RN; Inci, MK; Park, SH; Softic, S | 1 |
Chang, Y; Chen, K; Fan, X; Gao, XQ; He, J; Li, H; Li, HM; Lin, XH; Shen, N; Tian, FS | 1 |
Abdul Azees, PA; Barnes, JL; Das, F; Ghosh Choudhury, G; Kamat, A; Katz, MS; Pizzini, J; Shi, Y; Wang, H; Weintraub, ST; Yeh, CK; Zang, M | 1 |
Arita, J; Enooku, K; Fujiwara, N; Fukayama, M; Hasegawa, K; Hayashi, A; Hayata, Y; Hikiba, Y; Hirata, Y; Hirschfield, H; Hoshida, Y; Koike, K; Kudo, Y; Misumi, K; Nakagawa, H; Nakatsuka, T; Otsuka, M; Shibahara, J; Tanaka, M; Tanaka, Y; Tateishi, K; Tateishi, R | 1 |
Caballero, AE; Duggirala, R; González-Chávez, A; Herrera-Rosas, A; Ibarra-González, I; León-Hernández, M; López-Alvarenga, JC; Mummidi, S; Romero-Ibarguengoitia, ME; Serratos-Canales, MF; Vadillo-Ortega, F | 1 |
Gong, L; He, RR; Hong, M; Kurihara, H; Li, YF; Tian, JY; Wang, GE; Wu, YP; Yao, N; Zhai, YJ | 1 |
Bennett, M; Charlton, M; Chung, C; Harrison, SA; Harting, E; Kayali, Z; Lai, M; Lawitz, EJ; Loomba, R; McColgan, BJ; Middleton, MS; Myers, RP; Noureddin, M; Ray, AS; Ruane, P; Subramanian, GM; Tarrant, JM; Wang, L | 1 |
Bai, JY; Gao, X; Li, XY; Li, Y; Lu, Y; Xia, P; Xu, X; Zhu, XP | 1 |
Bureau, Y; Cheung, A; Chiu, J; Dunlop, K; Guglielmo, CG; Lee, TY; Mathers, KE; Raha, S; Regnault, TRH; Sarr, O; Zhao, L | 1 |
Phowthongkum, P; Shotelersuk, V; Suphapeetiporn, K | 1 |
Enooku, K; Fujiwara, N; Hoshida, Y; Koike, K; Kondo, M; Minami, T; Nakagawa, H; Shibahara, J; Tateishi, R | 1 |
Akaza, K; Bunai, Y; Ishii, A; Nagai, A; Nishida, N; Yamaguchi, S | 1 |
Cusi, K; Garrett, TJ; Kalavalapalli, S; Martinez, J; Mathew, JT; McDougall, DJ; Nautiyal, M; Patterson, RE; Reinhard, MK; Rocca, JR; Sunny, NE; Williams, CM; Yost, RA | 1 |
Britton, SL; Burgess, SC; Fletcher, JA; Fu, X; Ibdah, JA; Koch, LG; Meers, GM; Morris, EM; Rector, RS; Shankar, K; Thyfault, JP | 1 |
Calvisi, DF; Feo, CF; Feo, F; Pascale, RM; Simile, MM | 1 |
Merali, C; Merali, S; Quinn, C; Rico, MC | 1 |
Li, H; Li, W; Li, Z; Liu, Q; Wang, D; Wang, L; Wang, S; Wu, L; Xu, Y; Ye, F; Zhang, A; Zhang, J | 1 |
Barbier-Torres, L; Fan, W; Lu, SC; Mato, JM; Murray, B | 1 |
Baldini, F; Khalil, M; Miraglia, N; Putignano, P; Vergani, L; Voci, A | 1 |
Goto, H; Hidoh, Y; Ishii, Y; Nishimura, Y; Sato, M; Takeuchi, K; Yokouchi, C | 1 |
Battaglia-Hsu, SF; Dai, Z; Feng, J; Guo, T; Li, B; Li, Z; Wang, F; Yang, J; You, K | 1 |
Abeynayake, A; Barbier-Torres, L; Berlind, J; Binek, A; Erbay, E; Fan, W; Lu, SC; Mato, JM; Nissen, NN; Noureddin, M; Ramani, K; Robinson, AE; Van Eyk, JE; Yildirim, Z | 1 |
Armengol, L; Arola, L; Caimari, A; Maria Del Bas, J; Mariné, S; Moriña, D; Puiggròs, F; Rodríguez, B; Rodríguez, MA | 1 |
Antofiychuk, N; Antoniv, A; Danylyshina, T; Shuper, V; Trefanenko, I | 1 |
Byun, S; Guo, G; Kemper, B; Kemper, JK; Kim, YC; Kong, B; Ma, J; Seok, S; Xie, W; Zhang, Y | 1 |
García-Román, J; García-Román, R; Gómez-Ñañez, I; Mora, SI | 1 |
Ali, MA; Bakir, MB; Kamel, MA; Khalifa, EA; Refaat, R; Salama, MA | 1 |
Kozlov, VK; Stel'makh, VV | 1 |
Aspichueta, P; Aurrekoetxea, I; Buqué, X; Fernández-Ares, L; Fernandez-Ramos, D; Finnell, RH; Fresnedo, O; García-Monzón, C; García-Orad, A; Gutiérrez-de Juan, V; Lu, SC; Luka, Z; Martin-Guerrero, I; Martínez-Chantar, ML; Martínez-Uña, M; Mato, JM; Mestre, D; Varela-Rey, M; Wagner, C | 1 |
Lu, SC; Mato, JM; Noureddin, M | 1 |
Noureddin, M; Rinella, ME | 1 |
Alonso, C; Anguita, J; Aransay, AM; Aspichueta, P; Crespo, J; de Juan, VG; delaCruz-Villar, L; Falcón-Pérez, JM; Fernández-Ramos, D; Ilisso, CP; Iruarrizaga-Lejarreta, M; Lavín Trueba, JL; Lu, SC; Martín-Duce, A; Martínez-Arranz, I; Martínez-Chantar, ML; Mato, JM; Mayo, R; Mincholé, I; Navasa, N; Noureddin, M; Platon, J; Robinson, A; Romero-Gómez, M; Sann, H; Van Eyk, J; Van Liempd, SM; Varela-Rey, M | 1 |
Aspichueta, P; Aurrekoetxea, I; Buqué, X; Cano, A; García-Rodríguez, JL; Lu, SC; Martínez-Chantar, ML; Martínez-Uña, M; Mato, JM; Menor, A; Ochoa, B | 1 |
Dettmer, K; Gronwald, W; Hellerbrand, C; Klein, MS; Oefner, PJ; Reinders, J; Stevens, AP; Thomas, A | 1 |
Kozlov, VK; Nekrasova, AS; Radchenko, VG; Stel'makh, VV | 1 |
6 review(s) available for s-adenosylmethionine and Fatty Liver, Nonalcoholic
Article | Year |
---|---|
Fructose impairs fat oxidation: Implications for the mechanism of western diet-induced NAFLD.
Topics: Animals; Carnitine; Diet, High-Fat; Diet, Western; Dietary Fats; Fructose; Humans; Liver; Non-alcoholic Fatty Liver Disease; PPAR alpha | 2023 |
S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent.
Topics: Animals; Antiviral Agents; Betaine; Carcinogenesis; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Colorectal Neoplasms; Humans; Liver Neoplasms; Male; Methionine Adenosyltransferase; Non-alcoholic Fatty Liver Disease; Rats; Ribavirin; S-Adenosylmethionine | 2022 |
Methionine adenosyltransferases in liver cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Dedifferentiation; Cell Transformation, Neoplastic; Disease Models, Animal; Disease Progression; Down-Regulation; Gene Expression Regulation, Enzymologic; Hepatocytes; Humans; Isoenzymes; Liver; Liver Neoplasms; Methionine Adenosyltransferase; Mice; Mice, Knockout; Non-alcoholic Fatty Liver Disease; S-Adenosylmethionine | 2019 |
Chronic liver diseases and the potential use of S-adenosyl-L-methionine as a hepatoprotector.
Topics: Animals; Cholestasis, Intrahepatic; Chronic Disease; Comorbidity; Cytoprotection; Dietary Supplements; Humans; Liver; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Risk Factors; S-Adenosylmethionine; Treatment Outcome | 2018 |
Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine.
Topics: Animals; Biomarkers; Disease Models, Animal; Humans; Liver; Mice; Non-alcoholic Fatty Liver Disease; Phosphatidylcholines; Phosphatidylethanolamines; S-Adenosylmethionine; United States | 2015 |
Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoprevention; Diabetes Mellitus, Type 2; Endoplasmic Reticulum Stress; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Incidence; Inflammation; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Leptin; Liver Neoplasms; Metformin; Non-alcoholic Fatty Liver Disease; Obesity; Risk Factors; S-Adenosylmethionine; Toll-Like Receptors | 2015 |
3 trial(s) available for s-adenosylmethionine and Fatty Liver, Nonalcoholic
Article | Year |
---|---|
Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach.
Topics: Adolescent; Adult; Amino Acids; Carnitine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Humans; Male; Medical History Taking; Metabolomics; Middle Aged; Models, Biological; Non-alcoholic Fatty Liver Disease; Obesity | 2018 |
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease.
Topics: Acetyl-CoA Carboxylase; Biomarkers; Carnitine; Double-Blind Method; Elasticity Imaging Techniques; Fatty Liver; Female; Humans; Isobutyrates; Liver Cirrhosis; Magnetic Resonance Imaging; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Oxazoles; Pyrimidines | 2018 |
[Metabolic correction of dyslipidemia in patients with nonalcoholic fatty liver disease as a new therapy policy].
Topics: Adult; Aged; Dyslipidemias; Fatty Liver; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Non-alcoholic Fatty Liver Disease; S-Adenosylmethionine; Succinates; Treatment Outcome; Young Adult | 2013 |
26 other study(ies) available for s-adenosylmethionine and Fatty Liver, Nonalcoholic
Article | Year |
---|---|
A targeted metabolomic profiling of plasma acylcarnitines in nonalcoholic fatty liver disease.
Topics: Adult; Biomarkers; Carnitine; Case-Control Studies; Chromatography, High Pressure Liquid; Female; Humans; Male; Metabolome; Metabolomics; Middle Aged; Non-alcoholic Fatty Liver Disease; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2020 |
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Carnitine; Fatty Liver; Formoterol Fumarate; Gene Expression; Hepatic Stellate Cells; Lipid Metabolism; Lipogenesis; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Phosphatidate Phosphatase; Receptors, Adrenergic, beta-2; Triglycerides | 2021 |
CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity.
Topics: Adult; Aged; Animals; Carcinoma, Hepatocellular; Carnitine; Carnitine O-Palmitoyltransferase; Case-Control Studies; Disease Models, Animal; Female; Humans; Liver Neoplasms; Male; Mice; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity | 2018 |
Theacrine protects against nonalcoholic fatty liver disease by regulating acylcarnitine metabolism.
Topics: Animals; Apolipoproteins E; Carnitine; Diet, High-Fat; Energy Metabolism; Male; Mice; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Oleic Acid; Plant Extracts; Protective Agents; Signal Transduction; Uric Acid | 2018 |
Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3.
Topics: Acetylation; Acyl-CoA Dehydrogenase, Long-Chain; Animals; Berberine; Carnitine; Diet, High-Fat; Drug Evaluation, Preclinical; Enzyme Activation; Fatty Acids; Glucose; Insulin Resistance; Lipid Metabolism; Male; Metabolome; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Liver; Non-alcoholic Fatty Liver Disease; Obesity; Oxidation-Reduction; Protein Processing, Post-Translational; Sirtuin 3 | 2019 |
Western diet consumption through early life induces microvesicular hepatic steatosis in association with an altered metabolome in low birth weight Guinea pigs.
Topics: Animals; Animals, Newborn; Birth Weight; Carnitine; Diet, Western; Fatty Acids; Female; Guinea Pigs; Lipogenesis; Liver; Metabolome; Non-alcoholic Fatty Liver Disease; Placental Insufficiency; Pregnancy; Weight Gain | 2019 |
Carnitine palmitoyl transferase 1A deficiency in an adult with recurrent severe steato hepatitis aggravated by high pathologic or physiologic demands: A roller-coaster for internists.
Topics: Adult; Anti-Bacterial Agents; Carnitine; Carnitine O-Palmitoyltransferase; Escherichia coli Infections; Humans; Hypoglycemia; Lipid Metabolism, Inborn Errors; Liver; Male; Mutation, Missense; Non-alcoholic Fatty Liver Disease; Recurrence; Severity of Illness Index | 2019 |
Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma.
Topics: Adult; Age Factors; Aged; Carcinoma, Hepatocellular; Carnitine; Disease Progression; Female; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Non-alcoholic Fatty Liver Disease | 2019 |
A case of sudden death after Japanese encephalitis vaccination.
Topics: Anaphylaxis; Arrhythmias, Cardiac; Autopsy; C-Reactive Protein; Carnitine; Cause of Death; Child; Death, Sudden; Encephalitis, Japanese; Fatal Outcome; Heart Arrest; Humans; Japanese Encephalitis Vaccines; Male; Non-alcoholic Fatty Liver Disease; Psychotropic Drugs; Tandem Mass Spectrometry; Uncertainty | 2015 |
Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity.
Topics: Animals; Carbon Isotopes; Carnitine; Ceramides; Chromatography, Liquid; Citric Acid Cycle; Dietary Fats; Dietary Sucrose; Diglycerides; Disease Models, Animal; Fatty Acids, Nonesterified; Fructose; Glucose Clamp Technique; Inflammation; Insulin Resistance; Liver; Magnetic Resonance Spectroscopy; Metabolome; Mice; Mitochondria, Liver; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; Real-Time Polymerase Chain Reaction; RNA, Messenger; Severity of Illness Index; Tandem Mass Spectrometry; Trans Fatty Acids; Transcriptome | 2016 |
Aerobic capacity and hepatic mitochondrial lipid oxidation alters susceptibility for chronic high-fat diet-induced hepatic steatosis.
Topics: Aerobiosis; Animals; Carnitine; Citric Acid Cycle; Diet, High-Fat; Disease Susceptibility; Fatty Acids; Lipid Metabolism; Liver; Male; Mitochondria, Liver; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; Oxidative Stress; Pyruvic Acid; Rats; Triglycerides | 2016 |
Dysregulation of S-adenosylmethionine Metabolism in Nonalcoholic Steatohepatitis Leads to Polyamine Flux and Oxidative Stress.
Topics: Adult; Animals; Carcinoma, Hepatocellular; Disease Models, Animal; Female; Glycine N-Methyltransferase; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Mice; Middle Aged; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; Oxidative Stress; Polyamines; Proteomics; S-Adenosylmethionine | 2022 |
As3MT via consuming SAM is involved in arsenic-induced nonalcoholic fatty liver disease by blocking m
Topics: Animals; Arsenic; Fatty Acids; Liver; Mice; MicroRNAs; Non-alcoholic Fatty Liver Disease; S-Adenosylmethionine | 2023 |
New Perspectives of S-Adenosylmethionine (SAMe) Applications to Attenuate Fatty Acid-Induced Steatosis and Oxidative Stress in Hepatic and Endothelial Cells.
Topics: Animals; Cell Line, Tumor; Cell Movement; Endothelial Cells; Hepatocytes; Malondialdehyde; Nitric Oxide; Non-alcoholic Fatty Liver Disease; Oleanolic Acid; Oxidative Stress; Palmitic Acid; Rats; Reactive Oxygen Species; S-Adenosylmethionine | 2020 |
Reduction of fatty liver in rats by nicotinamide via the regeneration of the methionine cycle and the inhibition of aldehyde oxidase.
Topics: Administration, Oral; Aldehyde Oxidase; Animals; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Hydralazine; Lipid Droplets; Liver; Male; Methionine; Niacinamide; Non-alcoholic Fatty Liver Disease; Rats, Sprague-Dawley; S-Adenosylmethionine; Triglycerides | 2021 |
S-adenosylmethionine upregulates the angiotensin receptor-binding protein ATRAP via the methylation of HuR in NAFLD.
Topics: Adaptor Proteins, Signal Transducing; Animals; Diet, High-Fat; ELAV-Like Protein 1; Female; Humans; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Rats; Receptor, Angiotensin, Type 1; RNA, Messenger; S-Adenosylmethionine; Transfection; Up-Regulation | 2021 |
S-adenosylmethionine inhibits la ribonucleoprotein domain family member 1 in murine liver and human liver cancer cells.
Topics: Animals; Autoantigens; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin-Dependent Kinase 2; Humans; Liver Neoplasms; Methionine Adenosyltransferase; Mice; Mice, Knockout; Mutation; Non-alcoholic Fatty Liver Disease; Oligonucleotides; Phosphorylation; Protein Biosynthesis; Proteomics; Ribonucleoproteins; Ribosomal Proteins; RNA-Binding Proteins; RNA, Messenger; S-Adenosylmethionine; SS-B Antigen; TOR Serine-Threonine Kinases | 2022 |
Hepatic accumulation of S-adenosylmethionine in hamsters with non-alcoholic fatty liver disease associated with metabolic syndrome under selenium and vitamin E deficiency.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Cricetinae; Diet, High-Fat; Disease Progression; Humans; Liver; Male; Mesocricetus; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Oncogene Protein p55(v-myc); Protein Kinases; S-Adenosylmethionine; Selenium; Vitamin E | 2019 |
CLINICAL EFFICACY OF S-ADENOSYLMETHIONINE IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS AND CHRONIC KIDNEY DISEASE I-II STAGE.
Topics: Case-Control Studies; Humans; Methylhydrazines; Non-alcoholic Fatty Liver Disease; Obesity; Renal Insufficiency, Chronic; S-Adenosylmethionine | 2017 |
AhR and SHP regulate phosphatidylcholine and S-adenosylmethionine levels in the one-carbon cycle.
Topics: Animals; Carbon Cycle; Fibroblast Growth Factors; Glycine N-Methyltransferase; Humans; Liver; Male; Mice; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Phosphatidylcholines; Phosphatidylethanolamine N-Methyltransferase; Protein Binding; Receptors, Aryl Hydrocarbon; Receptors, Cytoplasmic and Nuclear; S-Adenosylmethionine | 2018 |
Evaluating the therapeutic potential of one-carbon donors in nonalcoholic fatty liver disease.
Topics: Animals; Betaine; Carbon; Choline; Diet, High-Fat; Dietary Supplements; DNA Methylation; Folic Acid; Glutathione; Homocysteine; Liver; Male; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; S-Adenosylmethionine | 2019 |
S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease.
Topics: Adult; Aged; Aged, 80 and over; Animals; Diet, High-Fat; Disease Models, Animal; Female; Glycine N-Methyltransferase; Humans; Lipoproteins, VLDL; Liver; Male; Membrane Proteins; Mice; Mice, Knockout; Middle Aged; Models, Biological; Non-alcoholic Fatty Liver Disease; Perilipin-2; S-Adenosylmethionine; Triglycerides; Young Adult | 2015 |
Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis.
Topics: Adult; Animals; Biomarkers; Ceramides; Diglycerides; Fatty Acids; Female; Humans; Lipid Metabolism; Male; Metabolome; Methionine Adenosyltransferase; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Non-alcoholic Fatty Liver Disease; S-Adenosylmethionine; Triglycerides | 2017 |
Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice.
Topics: Animals; Apolipoproteins B; Fatty Liver; Gene Deletion; Lipoproteins, VLDL; Liver; Male; Methionine Adenosyltransferase; Mice; Mice, Inbred C57BL; Mice, Knockout; Microsomes, Liver; Non-alcoholic Fatty Liver Disease; S-Adenosylmethionine; Triglycerides; Unfolded Protein Response | 2011 |
Early changes in the liver-soluble proteome from mice fed a nonalcoholic steatohepatitis inducing diet.
Topics: Analysis of Variance; Animals; Cholesterol; Diet; Electrophoresis, Gel, Two-Dimensional; Fatty Liver; Female; Glycerol; Immunohistochemistry; Liver; Metabolomics; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Proteome; Proteomics; Reproducibility of Results; S-Adenosylmethionine | 2012 |
[Pathogenetic therapy of metabolic syndrome at the stage of visceral lesions].
Topics: Adolescent; Adult; Aged; Fatty Liver; Female; Humans; Infusions, Intravenous; Male; Metabolic Syndrome; Middle Aged; Non-alcoholic Fatty Liver Disease; S-Adenosylmethionine; Severity of Illness Index; Succinates; Treatment Outcome; Young Adult | 2012 |